Pericardial empyema due to Actinomyces israelii, Aggregatibacter actinomycetemcomitans, and Fusobacterium nucleatum

Pol Arch Intern Med. 2019 Oct 30;129(10):714-715. doi: 10.20452/pamw.14902. Epub 2019 Jul 17.

Authors

Alexander Reisinger¹, Lucie-Marie Matzkies², Philipp Eller³, Friedrich Fruhwald⁴, Robert Krause⁵

Affiliations

¹ Intensive Care Unit, University Hospital Graz, Department of Internal Medicine, Medical University of Graz, Graz, Austria. [email protected]
² Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria
³ Intensive Care Unit, University Hospital Graz, Department of Internal Medicine, Medical University of Graz, Graz, Austria
⁴ Department of Cardiology, Medical University of Graz, Graz, Austria
⁵ Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria

PMID: 31316043
DOI: 10.20452/pamw.14902

No abstract available

Publication types

Case Reports

MeSH terms

Actinomycosis / complications
Actinomycosis / diagnosis
Actinomycosis / drug therapy
Aggregatibacter actinomycetemcomitans
Anti-Bacterial Agents / therapeutic use
Bacterial Infections / complications*
Bacterial Infections / diagnosis
Bacterial Infections / drug therapy
Empyema / diagnosis
Empyema / diagnostic imaging
Empyema / drug therapy
Empyema / etiology*
Fusobacterium Infections / complications
Fusobacterium Infections / diagnosis
Fusobacterium Infections / drug therapy
Fusobacterium nucleatum
Humans
Male
Middle Aged
Pasteurellaceae Infections / complications
Pasteurellaceae Infections / diagnosis
Pasteurellaceae Infections / drug therapy
Pericarditis / diagnosis
Pericarditis / diagnostic imaging
Pericarditis / drug therapy
Pericarditis / etiology*

Substances

Anti-Bacterial Agents